The Global Cardiovascular Innovation Center is a product commercialization consortium made possible by a $60 million grant from the State of Ohio’s Third Frontier Project. The consortium is led by Cleveland Clinic and is made up of other leading Ohio medical and research institutions including Case Western Reserve University, the Ohio State University, the University of Cincinnati, the University of Toledo and University Hospitals of Cleveland, along with leading industry and economic development partners.
Deadline: April 12, 2017